Iris Grossman

Company: Eleven Therapeutics

Job title: Chief Therapeutics Officer

Seminars:

xRNA-encoded GLP1 agonist: the Goldilocks solution for safe, durable and titratable therapy 12:40 pm

xRNA is a synthetic, chemically decorated version of mRNA with longer duration of effect We developed xGLP-1, an xRNA version to introduce GLP-1 peptides, while optimizing the sequence, chemistry and payload to boost in vivo potency and durability by several orders of magnitude Two routes of administration support the opportunity for possible self-administration and various…Read more

day: Day Two